Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Elevated Labile Plasma Iron Levels (LPI) and Increased Oxidative Stress Are Associated with Red Blood Cell Transfusions in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Subtitle: from the European Leukemianet MDS Registry

Marlijn Hoeks, MD, Saskia Langemeijer, MD PhD, Louise De Swart, MD, Tim Bagguley, Corine van Marrewijk, PhD, David Bowen, MD PhD, Jaroslav Cermak, Eva Hellstrom-Lindberg, MD PhD, Aurelia Tatic, MD, Argiris Symeonidis, Marian G.J. Van Kraaij, MD PhD, Panagiotis Panagiotidis, Hege Garelius, MD, Dominic J Culligan, Marta Krejci, MD PhD, Jackie Droste, PhD, Alexandra Smith, PhD, Dorine W. Swinkels, MD PhD, Theo de Witte, MD PhD

Blood (2016) 128 (22): 4327.

https://doi.org/10.1182/blood.V128.22.4327.4327

Published: 2016

Journal Articles

Deregulated Expression of Long Non-Coding RNAs UCA1, NEAT1 and BDNF-As in Multiple Myeloma

Lenka Sedlarikova, MSc, Barbora Gromesova, MSc, Jana Filipova, MSc, Veronika Kubaczkova, MSc, Lenka Radova, PhD, Martina Almasi, PhD, Miroslav Penka, MD PhD, Zdenek Adam, MD PhD, Ludek Pour, MD PhD, Marta Krejci, MD PhD, Sabina Sevcikova, RNDr, PhD, Roman Hajek, prof, MD PhD

Blood (2016) 128 (22): 2073.

https://doi.org/10.1182/blood.V128.22.2073.2073

Published: 2016

Journal Articles

Outcome of Third Salvage Autologous Stem Cell Transplantation in Multiple Myeloma

Blood (2016) 128 (22): 993.

https://doi.org/10.1182/blood.V128.22.993.993

Published: 2016

Journal Articles

Combination Of Lenalidomide, Dexamethasone and Cyclophosphamide as Treatment For The First Relapse Of Multiple Myeloma: Efficacy, Toxicity and Occurance Of Thyroid Abnormalities

Marta Krejci, MD, PhD, Zdenek Adam, Prof. MD, PhD, Ludek Pour, MD, PhD, Jana Pelcova, Jiri Mayer, MD, PhD

Blood (2013) 122 (21): 3233.

https://doi.org/10.1182/blood.V122.21.3233.3233

Published: 2013

Journal Articles

Long-Term Outcomes of Autologous Transplantation in Multiple Myeloma: Prognostic Significance of Complete Response.

Marta Krejci, MD, PhD, Roman Hajek, Prof. MD, PhD, Zdenek Adam, Prof. MD, PhD, Ludek Pour, MD, PhD, Lenka Zahradova, MD, PhD, Jana Pelcova, Jiri Mayer, M.D., PhD., Prof.

Blood (2012) 120 (21): 3126.

https://doi.org/10.1182/blood.V120.21.3126.3126

Published: 2012

Journal Articles

Prognostic Significance of Morphological Evaluation of Tumor Cells in Multiple Myeloma.

Mohammed Al-sahmani, MD, Irena Trnavska, Monika Antosova, Libuse Antosova, Jarmila Kissova, MD, Hana Filkova, M.Sc., Jan Smetana, M.Sc., Zdenek Adam, MD, Prof., Ludek Pour, MD, Marta Krejci, MD, Lenka Zahradova, MD, Alena Bulikova, MD, Miroslav Penka, Prof., Petr Kuglik, Ass., Prof., Roman Hajek, MD, Prof.

Blood (2009) 114 (22): 4889.

https://doi.org/10.1182/blood.V114.22.4889.4889

Published: 2009

Journal Articles

New Characteristics of Liver Gvhd: Kinetics, and the Serum Levels of Enzymes Linked to Cholestasis

Jiri Mayer, MD, Jan Kamelander, MD, Zdenek Pospisil, MSc, Michael Doubek, MD, PhD, Marta Krejci, MD, PhD

Blood (2008) 112 (11): 4359.

https://doi.org/10.1182/blood.V112.11.4359.4359

Published: 2008

Journal Articles

Chimerism Status as a Possible Marker of Incipient Disease Relapse in Patients with AML.

Ondrej Horky, MSc, Jiri Mayer, Prof., Marek Borky, MSc., Marta Krejci, MD, Sarka Pospisilova, PhD, Dana Dvorakova, PhD

Blood (2007) 110 (11): 5028.

https://doi.org/10.1182/blood.V110.11.5028.5028

Published: 2007

Journal Articles

Consolidation Therapy Based on Conventional Chemotherapy and Corticoids Do Not Provide Therapeutic Advantage for Newly Diagnosed Patients after Autologous Transplantation.

Blood (2007) 110 (11): 531.

https://doi.org/10.1182/blood.V110.11.531.531

Published: 2007

Journal Articles

Detection and Treatment of Molecular Relapse in Acute Myeloid Leukemia with RUNX1, CBFB or MLL Gene Translocations. Frequent Quantitative Monitoring of Molecular Markers in Different Compartments and Correlation with WT1 Gene Expression.

Michael Doubek, MD, PhD, Ivo Palasek, MD, Zdenek Pospisil, PhD, Sona Struncova, PhD, Dana Dvorakova, PhD, Marek Borsky, PhD, Martin Klabusay, PhD, Yvona Brychtova, MD, Marta Krejci, MD, PhD, Jiri Mayer, MD, PhD

Blood (2007) 110 (11): 4356.

https://doi.org/10.1182/blood.V110.11.4356.4356

Published: 2007

Journal Articles

Pulse Cyclophosphamide in the Treatment of Liver GvHD Unresponsive to Steroids.

Jiri Mayer, MD, PhD, Marta Krejci, MD, PhD, Michael Doubek, MD, PhD, Yvona Brychtova, MD

Blood (2005) 106 (11): 5332.

https://doi.org/10.1182/blood.V106.11.5332.5332

Published: 2005

Journal Articles

Real Cost of Allogeneic Nonmyeloablative Hematopoietic Stem Cell Transplantation for CML and Hypothetical Comparison with Imatinib Therapy.

Jiri Mayer, MD, PhD, Yvona Brychtova, MD, Marta Krejci, MD, PhD, Michael Doubek, MD, PhD

Blood (2005) 106 (11): 5552.

https://doi.org/10.1182/blood.V106.11.5552.5552

Published: 2005

Journal Articles

Pulse Cyclophosphamide (CY) in the Treatment of Acute GvHD Refratcory to Steroids.

Jiri Mayer, MD, Marta Krejci, MD, Michael Doubek, MD, Yvona Brychtova, MD

Blood (2004) 104 (11): 1248.

https://doi.org/10.1182/blood.V104.11.1248.1248

Published: 2004

Journal Articles

Comparison of Reduced-Intensity Conditioning Regimen and Conventional Conditioning Regimen for Allografting in Chronic Myeloid Leukemia in the First Chronic Phase.

Michael Doubek, MD, PhD, Marta Krejci, MD, PhD, Yvona Brychtova, MD, Jiri Mayer, MD, PhD

Blood (2004) 104 (11): 4658.

https://doi.org/10.1182/blood.V104.11.4658.4658

Published: 2004

Journal Articles

Angiotensin-I Converting Enzyme Inhibitors and the Survival of Patients with Multiple Myeloma Treated by Autologous Stem Cell Transplantation.

Tomas Buchler, MD, PhD, Marta Krejci, MD, PhD, Adam Svobodnik, PhD, Zdenek Adam, MD, PhD, Jiri Minarik, MD, Jaroslav Bacovsky, MD, PhD, Vlastimil Scudla, MD, PhD, Jiri Mayer, MD, PhD, Jiri Vorlicek, MD, PhD, Roman Hajek, MD, PhD

Blood (2004) 104 (11): 944.

https://doi.org/10.1182/blood.V104.11.944.944

Published: 2004

NARROW

Elevated Labile Plasma Iron Levels (LPI) and Increased Oxidative Stress Are Associated with Red Blood Cell Transfusions in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Subtitle: from the European Leukemianet MDS Registry

Deregulated Expression of Long Non-Coding RNAs UCA1, NEAT1 and BDNF-As in Multiple Myeloma

Outcome of Third Salvage Autologous Stem Cell Transplantation in Multiple Myeloma

Combination Of Lenalidomide, Dexamethasone and Cyclophosphamide as Treatment For The First Relapse Of Multiple Myeloma: Efficacy, Toxicity and Occurance Of Thyroid Abnormalities

Long-Term Outcomes of Autologous Transplantation in Multiple Myeloma: Prognostic Significance of Complete Response.

Prognostic Significance of Morphological Evaluation of Tumor Cells in Multiple Myeloma.

New Characteristics of Liver Gvhd: Kinetics, and the Serum Levels of Enzymes Linked to Cholestasis

Chimerism Status as a Possible Marker of Incipient Disease Relapse in Patients with AML.

Consolidation Therapy Based on Conventional Chemotherapy and Corticoids Do Not Provide Therapeutic Advantage for Newly Diagnosed Patients after Autologous Transplantation.

Detection and Treatment of Molecular Relapse in Acute Myeloid Leukemia with RUNX1, CBFB or MLL Gene Translocations. Frequent Quantitative Monitoring of Molecular Markers in Different Compartments and Correlation with WT1 Gene Expression.

Pulse Cyclophosphamide in the Treatment of Liver GvHD Unresponsive to Steroids.

Real Cost of Allogeneic Nonmyeloablative Hematopoietic Stem Cell Transplantation for CML and Hypothetical Comparison with Imatinib Therapy.

Pulse Cyclophosphamide (CY) in the Treatment of Acute GvHD Refratcory to Steroids.

Comparison of Reduced-Intensity Conditioning Regimen and Conventional Conditioning Regimen for Allografting in Chronic Myeloid Leukemia in the First Chronic Phase.

Angiotensin-I Converting Enzyme Inhibitors and the Survival of Patients with Multiple Myeloma Treated by Autologous Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only